"Amarantus Announces Positive Phase 2 Data for Elt
Post# of 30027
Posted On: 03/18/2016 4:30:31 PM
"Amarantus Announces Positive Phase 2 Data for Eltoprazine in Alzheimer's Aggression DECEMBER 08, 2015
http://www.amarantus.com/news/press-releases/...ltoprazine
Add to the list the boat load of patents."
Positive Phase II data does not equal FDA approved drug.
We have to get through phase III and the get approval before there is a patent."
I think what you must have meant was "add this to the list of potential indications for Elto if the drug is approved."
http://www.amarantus.com/news/press-releases/...ltoprazine
Add to the list the boat load of patents."
Positive Phase II data does not equal FDA approved drug.
We have to get through phase III and the get approval before there is a patent."
I think what you must have meant was "add this to the list of potential indications for Elto if the drug is approved."
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼